139 related articles for article (PubMed ID: 38066506)
1. Capacity assessment and spatial analysis of cervical cancer services in The Gambia.
Mali ME; Sanyang O; Harris KL; Sorensen J; Bittaye M; Nellermoe J; Price RR; Sutherland EK
BMC Womens Health; 2023 Dec; 23(1):660. PubMed ID: 38066506
[TBL] [Abstract][Full Text] [Related]
2. Geospatial analysis and impact of targeted development of breast cancer care in The Gambia: a cross-sectional study.
Sanyang O; Lopez-Verdugo F; Mali M; Moustafa M; Nellermoe J; Sorensen J; Bittaye M; Njie R; Singhateh Y; Sambou NA; Goldsmith A; Mohammed NI; Brownson KE; Price RR; Sutherland E
BMC Health Serv Res; 2021 Sep; 21(1):943. PubMed ID: 34503503
[TBL] [Abstract][Full Text] [Related]
3. An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa.
Coleman JS; Cespedes MS; Cu-Uvin S; Kosgei RJ; Maloba M; Anderson J; Wilkin T; Jaquet A; Bohlius J; Anastos K; Wools-Kaloustian K
J Low Genit Tract Dis; 2016 Jan; 20(1):31-7. PubMed ID: 26579842
[TBL] [Abstract][Full Text] [Related]
4. Availability of services for the diagnosis and treatment of infertility in The Gambia`s public and private health facilities: a cross-sectional survey.
Afferri A; Allen H; Dierickx S; Bittaye M; Marena M; Pacey A; Balen J
BMC Health Serv Res; 2022 Sep; 22(1):1127. PubMed ID: 36071443
[TBL] [Abstract][Full Text] [Related]
5. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
6. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
7. Introducing assisted reproductive technologies in The Gambia, a survey on the perspectives of Gambian healthcare professionals and medical students.
Bittaye H; Mooney JP; Afferri A; Balen J; Kay V
BMC Health Serv Res; 2023 Feb; 23(1):203. PubMed ID: 36855053
[TBL] [Abstract][Full Text] [Related]
8. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
[TBL] [Abstract][Full Text] [Related]
9. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.
Paul P; Winkler JL; Bartolini RM; Penny ME; Huong TT; Nga le T; Kumakech E; Mugisha E; Jeronimo J
Oncologist; 2013; 18 Suppl():6-12. PubMed ID: 24334477
[TBL] [Abstract][Full Text] [Related]
10. Provision of cervical cancer prevention services in Northern Uganda: a survey of health workers from rural health centres.
Obol JH; Lin S; Obwolo MJ; Harrison R; Richmond R
BMC Health Serv Res; 2021 Aug; 21(1):794. PubMed ID: 34380470
[TBL] [Abstract][Full Text] [Related]
11. HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia.
Davies P; Aluloski I; Arifdjanova D; Brcanski J; Davidzenka A; Durdyeva A; Gayrat Umarzoda S; Goshliyev K; Jovanovic V; Jugeli L; Kocinaj-Berisha M; Maistruk G; Naumovic T; Pilav A; Rzayeva G; Saribekyan K; Siljak S; Ten E; Valuta D; Veljkovic M; Yildirimkaya G; Ylli A; Zhylkaidarova A; Melnic E
Asian Pac J Cancer Prev; 2023 May; 24(5):1781-1788. PubMed ID: 37247301
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
[TBL] [Abstract][Full Text] [Related]
13. Perspectives of Screening-Eligible Women and Male Partners on Benefits of and Barriers to Treatment for Precancerous Lesions and Cervical Cancer in Kenya.
Ragan KR; Buchanan Lunsford N; Lee Smith J; Saraiya M; Aketch M
Oncologist; 2018 Jan; 23(1):35-43. PubMed ID: 28798272
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer in Zimbabwe: a situation analysis.
Kuguyo O; Matimba A; Tsikai N; Magwali T; Madziyire M; Gidiri M; Dandara C; Nhachi C
Pan Afr Med J; 2017; 27():215. PubMed ID: 28979617
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.
Joseph J; Demke O; Ameyan L; Bitilinyu-Bango J; Bourgoin B; Diop M; Guèye B; Kama J; Lubega M; Madzima B; Maparo T; Mhizha T; Musoke A; Nabadda S; Phiri T; Tchereni T; Wiwa O; Hariharan K; Peter T; Khan S
BMJ Open; 2023 Jan; 13(1):e065074. PubMed ID: 36609331
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
17. Health workers' perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia.
Lott BE; Halkiyo A; Kassa DW; Kebede T; Dedefo A; Ehiri J; Madhivanan P; Carvajal S; Soliman A
BMC Womens Health; 2021 May; 21(1):185. PubMed ID: 33941159
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
[TBL] [Abstract][Full Text] [Related]
19. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
[TBL] [Abstract][Full Text] [Related]
20. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
